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doi:10.1016/j.kjms.2012.02.001Abstract Wntless (GPR177) protein is a newly identified regulator of Wnt signals in
Drosophila, but its cellular function in mammals is still unclear. In this study, we explored
the expression pattern and potential cellular function of Wntless in mammalian cells.
Wntless mRNA was expressed in many mouse tissues, including the spleen, lung, kidney,
thymus, and stomach, and lower levels of expression were detected in the mouse brain
and testis. Expression of Wntless protein analyzed by Western blot and immunohistochemical
staining was only detected in the submucosa, muscle, ganglia, and nerve cells of murine
large intestines. Both immunofluorescence staining and subcellular fraction extraction anal-
ysis revealed that endogenous Wntless protein was expressed predominantly in the cyto-
plasmic organelles with a morphologically dot-shaped distribution. Furthermore,
overexpression of Wntless could be corrected by and may activate the nuclear factor-kB
(NF-kB) signaling pathway in cancer (HeLa) cells. These results suggest that Wntless
plays a role in signaling regulation during the formation of cancer in addition to its role as
a retromer protein in mammalian systems.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved.Introduction
Wnt signaling is important in embryonic segmentation, limb
development, and central nervous system (CNS) patterningnstitute of Medicine, Kaoh-
7, Taiwan.
.tw (S.-H. Hsu).
vier Taiwan LLC. All rights reserv[1], and interference in Wnt signaling promotes both
degenerative diseases and cancers in humans [2]. However,
the exact secretion mechanism of Wnt proteins is still
unclear. Recently, a new Wnt protein regulator, Wntless,
was identified in Drosophila and Caenorhabditis elegans
[3e6]. Wntless is a new segment polarity gene that encodes
a multipass transmembrane protein in Drosophila and is
necessary for Wnt secretion and wingless (Wg) signaling
throughout embryonic development [3,7]. An obvioused.
356 L.-T. Wang et al.characteristic of Wntless is its high degree of specificity;
although it is known to control the secretion of Wnt
proteins, to date the secretion of other proteins has not
been found to be influenced by damage to the Wntless
function [3,4,8e10]. In Drosophila, Wntless protein was
found to be localized in some organelles, such as the Golgi
network and endosomes and was considered to cycle
between the compartments that regulate Wnt protein
secretion [11,12]. It has been suggested that Wntless plays
an important role in embryonic development and it was
demonstrated that the retromer for Wnt secretion is
regulated by Wntless (GPR177)-binding protein-opioid
receptor in the nervous system [13]. However, the exact
mechanism by which Wnt protein secretion is regulated by
Wntless is still unknown. Thus, although Wntless appears to
play an important role in tumor growth and development,
its physiological function in mammalian cells remains
unclear.
Nuclear factor-kB (NF-kB), an inducible transcription
factor, plays a critical role in many biological processes,
including inflammation, apoptosis, development of cancer,
and immediate and long-term cellular responses that
govern environmental plasticity [14,15]. The five members
of the mammalian NF-kB family, namely p65 (RelA), RelB,
c-Rel, p50/p105 (NF-kB1), and p52/p100 (NF-kB2), are
present in unstimulated cells as homo or heterodimers
bound to IkB family proteins. Binding to IkB prevents the
NF-kB/IkB complex from translocating to the nucleus,
thereby maintaining NF-kB in an inactive state [16e18]. NF-
kB signaling is generally considered to occur through either
a classical or alternative pathway [16,19]. The classical
pathway of NF-kB activation is stimulated by the proin-
flammatory cytokine, tumor necrosis factor a (TNFa),
resulting in the activation of the b subunit of the IkB kinase
(IKK) complex, which then phosphorylates IkB proteins on
two N-terminal serine residues [20]. In the alternative
pathway, IKKa is activated and phosphorylates p100.
Phosphorylated IkBs are recognized by the ubiquitin ligase
machinery, which leads to their polyubiquitination and
subsequent degradation (or processing in the case of p100)
by the proteasome [17,19]. The freed NF-kB dimers trans-
locate into the nucleus, where they bind to specific
sequences in the promoter or enhancer regions of the
target genes. Activated NF-kB can then be down-regulated
through multiple mechanisms, including a well character-
ized feedback pathway, whereby newly synthesized IkBa
protein binds to nuclear NF-kB, which exports it out to the
cytoplasm [17]. NF-kB also regulates the expression of
genes outside the immune system and can thus influence
multiple aspects of normal and disease physiology [16,17].
Recent work has highlighted the role of NF-kB in embryonic
development and in the development and physiology of
tissues, such as the mammary gland, bone, skin, and
central nervous system [17,19].
In this study, we explored the expression pattern and
potential physiological function of Wntless in mammalian
cells. We found that Wntless showed the same expression
pattern as Wnt protein in mammalian large intestine
cells. Overexpression of Wntless activated molecular NF-kB
signaling expression. It was therefore suggested thatWntless
may possess an additional and novel function in the regula-
tion of the NF-kB signaling pathway.Methods
Plasmids
Wntless full-length cDNA (accession number: AK 159207),
D3 (1e363 amino acid) and D5 (307e541 amino acid)
truncates tagged with enhanced green fluorescent
protein (EGFP) were subcloned into pEGFP N3 vector
(Invitrogen).RNA extraction and Northern blot analysis
Mouse tissue total RNA was isolated by Trizol reagent
(GIBCO/BRL) as previously described [21], and mRNAs were
extracted using mRNA extract kit (Qiagen). Using Northern
blots, samples containing 2 mg of mRNA were electro-
phoresed by 1.2% formaldehyde-agarose gel, transferred to
Hybond-N nylon membranes (Amersham) by capillary blot-
ting in 10 saline sodium citrate (SSC), and hybridized with
a wntless cDNA probe (base pairs 201e1001).Subfraction of cellular protein extraction
Cellular proteins in different fractions (cytoplasm,
membrane/organelle, nucleus, and cytoskeleton) from
HeLa cells (3e5106) were isolated by ProteoExtract
Subcellular Proteome Extraction kit (Merck Millipore) as
previously described [22]. Briefly, the process is described
as follows. After washing with cold phosphate-buffered
saline (PBS), cells were treated with cytoplasmic protein
extraction buffer to isolate cytoplasm fraction proteins.
Then, the membrane/organelle proteins were extracted by
membrane/organelle buffer. Finally, the nuclear and
cytoskeletal proteins were extracted by adding nuclear
protein and cytoskeletal matrix buffer, separately.Immunofluorescence analysis
HeLa cells were cultured on coverslides precoated with
poly-L-lysine for 16 hours under standard conditions. After
washing with cold PBS, cells were fixed with 4% para-
formaldehyde in PBS at 37 C for 30 minutes, and the slides
were washed three times with PBST (0.2% triton in PBS) on
ice for 10 minutes. Cells were blocked with 2% bovine serum
albumin (BSA) in PBS for 30 min at 37 C, and the slides
were washed with PBST to remove blocking buffer. Cells
were then incubated in anti-Wntless, p-p65 and p52 poly-
clonal antibody (1:200) for 2 hours. After washing three
times in PBST, fluorescein isothiocyanate (FITC)-conjugated
human anti-rabbit and mouse polyclonal antibody (1:200)
was added and cells were incubated for 1 hour at room
temperature in a humidity chamber. After washing cover
slides three times in PBST, cells were finally counterstained
with 40-6-diamidino-2-phenylindole (DAPI) for 3e5 minutes
to localize the nucleus and observed by confocal micros-
copy. Brefeldin A (Molecular Probes) staining for Golgi
apparatus and endoplasmic reticulum (ER) was performed
as per manufacturer’s protocol.
Figure 1. Expression of Wntless in different adult tissues by
Northern blot and analysis of Wntless recognized with anti-
Wntless polyclonal antibody by Western blot. (A) Wntless is
expressed in multiple mouse tissues. BZ brain; HZ heart;
KZ kidney; LiZ liver; LuZ lung; OvZ ovary; SpZ spleen;
StZ stomach; TeZ testis; ThyZ thymus; UtZ uterus. (B)
Polyclonal rabbit anti-Wntless antibody could specifically
recognize the endogenous (right panel) and enhanced green
fluorescent protein (EGFP)-tagged recombinant (left panel)
Wntless proteins. Arrow: Wntless proteins are indicated as
endogenous (*) and EGFP-tagged proteins.
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The promoter region of NF-kB (p65) from þ27 bp to
e1273 bp was isolated from human placenta genomic DNA
and then subcloned into a luciferase reporter system (pGL3;
Promega). The Wntless and Wntless mutants (D3 and D5)
expression constructs and two reporters, pSV40-Rluc and
pGL3-p65/Fireflyluciferase, were separately cotransfected
into 2105 HeLa cells as previously described [22]. Cells
wereharvested 16 hours after transfection and relative
luciferase activities were measured according to the
manufacturer’s instructions.
Western blot and immunohistochemical staining
analysis
Western blot analysis and immunohistochemical staining
were performed as described [21,23,24]. The primary
antibodies used in this study were b-actin polyclonal anti-
body (1:2000; Santa Cruz, I-19), hsp-70, Cadherin, Vimen-
tin, C-Rel, Rel-B, B23 polyclonal antibody (1:2000; Santa
Cruz), Histone 1, p65, p100, and p105 antibodies (1:500;
Cell Signaling Technology), FITC-conjugated anti-mouse,
alkaline phosphatase-conjugated anti-rabbit antibodies
(1:500; Jackson ImmunoResearch Laboratory) and Wntless
rabbit polyclonal antibody (1:5000; produced in-house).
Results
Expression patterns of Wntless
The gene expression pattern was firstly characterized as
mRNA and protein expression in a multitude of mouse
tissues. The transcript of Wntless was detected in a variety
of normal mouse tissues by Northern blot analysis. Wntless
mRNA was detected in several mouse tissues including the
spleen, lung, kidney, intestine, and thymus, and a lower
expression level was found in the stomach, brain, and
testes (Fig. 1A). To identify the expression pattern of
Wntless protein in more detail, three oligopeptides
(119e130, 151e162, and 485e496 amino acids) from
Wntless protein were used to immunize rabbits and obtain
anti-Wntless antibody. As shown in Fig. 1B (right), the anti-
Wntless rabbit antibody could specifically recognize both
the endogenous and EGFP-fused Wntless protein.
Characterization of Wntless expression and cellular
location in adult mice
To characterize the cellular function of Wntless, cellular
expression of Wntless protein was further analyzed in
different mouse tissues and HeLa cell lines by Western
blotting, immunohistology, and immunofluorescence. Total
proteins extracted from various mouse tissues were
analyzed by Western blot. In normal mouse tissues, Wntless
protein was only detected in the large intestine (Fig. 2A).
Analysis by immunohistochemical staining further
confirmed that Wntless protein was expressed predomi-
nantly in the submucosa, muscle cells, and nerve cells
(including ganglia) of mouse large intestine; the sameexpression pattern was observed for Wnt protein in
a previous study [25] (Fig. 2A and 2B).
To understand its cellular function further, the cellular
localization of endogenous Wntless protein in human tumor
(HeLa) cells was monitored using anti-Wntless antibody
(generated as described above) with immunofluorescence
staining under a confocal microscope. Wntless protein
(green) was mainly expressed in the cytoplasm as scattered
dots and some dots of expression were colocalized in the
Golgi apparatus (stained with brefeldin A; red) (Fig. 2C). In
a cellular subfraction of HeLa cells, Wntless protein was
detected predominantly in the membrane/organelle frac-
tion and to a lesser extent in the nucleus and cytoskeleton
(Fig. 2D). Its cellular distribution suggested that Wntless
may be a membrane-associated protein with different
localization activity and further conformation to a retromer
protein.
NF-kB signaling pathway was activated by Wntless
The cellular signaling pathway regulated by Wntless was
further analyzed by overexpression (ectopic) of different
Figure 2. Wntless expression pattern and cellular location in mouse tissue and cells. (A) Expression tissue of Wntless in mouse.
BZ brain; HZ heart; L.I.Z large intestine; LiZ liver; LuZ lung; S.I.Z small intestine; SpZ spleen; StZ stomach. Arrow:
Wntless protein. (B) Immunohistochemistry staining of Wntless in large intestine. Arrow: nonsense band; Wntless, brown color. (C)
Wntless localized in membrane and less expression in nuclei. Nuclei, blue (DAPI); Wntless, green; Golgi and ER, red (Brefeldin A).
(D) Cellular subfraction distribution of Wntless. Wntless recognized with anti-Wntless antibody. Cadherin, organelle/membrane
marker; Histone 1, nucleus marker; Vimentin, cytoskeleton marker.
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The cellular function of the conserved domain in Wntless
was also confirmed using different truncated constructs.
Full-length Wntless-, Wntless D3 (Wls D3, 1e363 amino
acids)- and Wntless D5 (Wls D5, 307e542 amino acids)-EGFP
fusion proteins driven by a cytomegalovirus promoter were
expressed in HeLa cells (Fig. 3A). The NF-kB (p65) promoter
region (þ27 bp to e1273 bp) was amplified from human
placental genomes by polymerase chain reaction and
subcloned into a firefly luciferase expression construct
(PGL3). As shown in Fig. 3B, HeLa cells transfected with
Wntless and truncated Wntless (D3) protein significantly
increased the luciferase activity driven by the p65
promoter compared with mock-transfected cells. HeLa
cells transfected with truncated Wntless (D5) showed no
increase in luciferase activity. The nuclear and cytoplasmic
fractions of Wntless-transfected HeLa cells were separated
and expression levels of NF-kB members were determined
by Western blot analysis. As shown in Fig. 3C, transient
Wntless transfection not only induced a significant increase
in p65, p100 (p52), and p50 expression but also activated
protein translocation from the cytoplasm into the nucleus
compared with the vector. Wntless D3 induced a slightincrease in p65, p100 (p52), and p50 protein translocation
into the nucleus. In particular, overexpression of Wntless
also increased cytoplasmic c-Rel expression levels and
nuclear RelB expression. To confirm the effect on protein
translocation induced by Wntless, HeLa cells transfected
with Wntless were analyzed by immunofluorescence under
confocal microscopy. As shown in Fig. 3D, when Wntless
(green) was overexpressed in HeLa cells, p65 and p52 (red)
were increased and mainly localized in the nuclei.Discussion
In this study, Wntless mRNA was detected in several mouse
tissues including the lung, kidney, and thymus, and low
expression levels were observed in the spleen, stomach,
brain, and testis; however, Wntless protein was only
detected in the large intestine. Cellular Wntless protein
was mainly localized in the cytoplasm with a dot-shaped
distribution and little was detected in the nuclei. In addi-
tion, overexpression of Wntless activated NF-kB signaling
molecules (p65, p52, RelB, and P50) in the nuclei. These
results suggested that Wntless plays a novel role in
Figure 3. Nuclear factor-kB (NF-kB) signaling pathway was activated by overexpression of Wntless protein. (A) Constructs of
three different EGFP-tagged Wntless proteins. Full-length, C-terminal (D3), and N-terminal (D5) truncated Wntless protein
expression constructs were transfected into HeLa cells individually. (B) Wntless and Wntless mutant (D3) activated NF-kB (p65)
promoter-driven relative luciferase activity. *** p< 0.001. (C) Wntless protein activates the NF-kB signaling pathway. Wntless and
truncated Wntless (D3) protein increased the cellular translocation of NF-kB in HeLa cells. CZ cytoplasm; NZ nuclear protein. The
members of NF-kB are indicated by arrowheads (◄). B23, nuclear marker. (D) Cellular localization of NF-kB (p65 and p52) in normal
and Wntless-transfected cells. EGFP-tagged Wntless, green; NF-kB, red; nucleus, blue (DAPI).
Wntless activates NF-kB signaling 359regulating NF-kB signaling in addition to its role as a retro-
mer protein for Wnt protein secretion.
As a retromer protein for Wnt protein secretion, it was
shown that the Wntless protein in Drosophila was localized
in the Golgi apparatus, the ER, and endosomes [26].
Wntless protein was mainly expressed during early embry-
onic development in Drosophila, but its expression pattern
in adult Drosophila and mammalian systems was still
unclear. In this study, Wntless protein was detected in the
large intestine in adult mice and this tissue-specific
expression pattern was consistent with that of Wnt
protein in mice, suggesting that Wntless is involved in
human diseases induced by dysregulation of Wnt signaling.
Dysregulation of Wnt signaling has been shown to be asso-
ciated with many human cancers, such as colon cancer;
dysfunctional Wnt signaling molecules, namely, Wnt-1,
APC, and b-catenin, have been detected in colon cancerpatients. Several lines of convergence in developmental
biology and molecular oncology have suggested a crucial
role for mutations in activating the Wnt pathway and
causing colorectal tumors. The pivotal event appears to be
the formation of a constitutively active b-catenin/Tcf4
complex in the intestinal epithelial cells. The expression
pattern of Wntless, as the regulator of Wnt protein secre-
tion, further suggested that Wntless plays an important
regulatory role in Wnt signaling-associated colon cancer.
One of the major findings in this study suggested that
Wntless activates NF-kB signaling. Activated NF-kB is
a transcriptional regulatory dimer comprised of different
NF-kB member proteins that bind a common sequence
motif known as the kB site [27e29]. Several regulatory
proteins tightly control this signaling pathway, and disrup-
tion of this process has been associated with various
hematological malignancies, as well as epithelial tumors
360 L.-T. Wang et al.such as breast cancer, lymphoma, and gastric tumors
[16,17]. Constitutively activated NF-kB signals have been
described in multiple systems but whether they increase
cell proliferation, protect cells, or promote apoptosis
appears to depend on the cell type and the method used to
induce apoptosis [16,30e32]. This varied response is
undoubtedly related to the fact that NF-kB promotes
protein expression in proliferation, anti-apoptosis, and pro-
apoptosis. NF-kB activation also reportedly occurs during
cell reattachment, which has been exploited as a target to
prevent the survival of metastatic cells [33]. In this study,
we suggested that NF-kB signaling members (p65, p50, p52,
and RelB) were activated in vitro by the retromer protein
Wntless, but the exact regulatory mechanism needs further
elucidation.
In summary, we found that Wntless is mainly expressed
in mammalian epithelial cells of the large intestine. The
cellular Wntless proteins were detected mainly in the
organelle fraction and little was found in the nuclei. In
addition, constitutive Wntless expression can activate the
NF-kB signaling pathway. This result appears to provide
a new insight into tumorigenesis and tumor therapy.Acknowledgments
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